Multiple Assemblies exist for SMTL entry 1ncq
The structure of HRV14 when complexed with pleconaril, an antiviral compound; X-RAY DIFFRACTION 2.50 Å

	SMTL ID 1ncq.1 Ligands 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4 Oligo-state hetero-1-1-1-1-mer
	SMTL ID 1ncq.2 Ligands 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4 Oligo-state hetero-5-5-5-5-mer
	SMTL ID 1ncq.3 Ligands 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4 Oligo-state hetero-6-6-6-6-mer
	SMTL ID 1ncq.4 Ligands 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4 Oligo-state hetero-1-1-1-1-mer